DOP2013000258A - Formulaciones de liberación sostenida de paracetamol - Google Patents

Formulaciones de liberación sostenida de paracetamol

Info

Publication number
DOP2013000258A
DOP2013000258A DO2013000258A DO2013000258A DOP2013000258A DO P2013000258 A DOP2013000258 A DO P2013000258A DO 2013000258 A DO2013000258 A DO 2013000258A DO 2013000258 A DO2013000258 A DO 2013000258A DO P2013000258 A DOP2013000258 A DO P2013000258A
Authority
DO
Dominican Republic
Prior art keywords
paracetamol
sustained release
release formulations
release phase
paracetamol sustained
Prior art date
Application number
DO2013000258A
Other languages
English (en)
Inventor
Carla Valenti Buan
Dongzhou Liu
Kanji Meghpara
Original Assignee
Glaxosmithkline Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxosmithkline Llc filed Critical Glaxosmithkline Llc
Publication of DOP2013000258A publication Critical patent/DOP2013000258A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

LA INVENCION PRESENTE ESTA DIRIGIDA A UNA COMPOSICION FARMACEUTICA DE LIBERACION SOSTENIDA DE DOS VECES AL DIA DE PARACETAMOL QUE TIENE UNA FASE DE LIBERACION INMEDIATA DE PARACETAMOL Y UNA FASE DE LIBERACION SOSTENIDA DE PARACETAMOL, DICHA COMPOSICION TIENE PROPIEDADES FARMACOCINETICAS UNICAS Y VENTAJOSAS Y UNA COMPOSICION FARMACEUTICA QUE COMPRENDE SOLO UNA FASE DE LIBERACION SOSTENIDA DE PARACETAMOL QUE TIENE PROPIEDADES FARMACOCINETICAS UNICAS Y VENTAJOSAS.
DO2013000258A 2011-05-06 2013-11-06 Formulaciones de liberación sostenida de paracetamol DOP2013000258A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201161483320P 2011-05-06 2011-05-06

Publications (1)

Publication Number Publication Date
DOP2013000258A true DOP2013000258A (es) 2014-07-15

Family

ID=47139543

Family Applications (1)

Application Number Title Priority Date Filing Date
DO2013000258A DOP2013000258A (es) 2011-05-06 2013-11-06 Formulaciones de liberación sostenida de paracetamol

Country Status (19)

Country Link
US (1) US20140065213A1 (es)
EP (1) EP2704697B1 (es)
CN (1) CN103648486A (es)
AP (1) AP3878A (es)
AU (1) AU2012253834B2 (es)
BR (1) BR112013028668A2 (es)
CA (1) CA2835330A1 (es)
CL (1) CL2013003176A1 (es)
CO (1) CO6801767A2 (es)
CR (1) CR20130572A (es)
DO (1) DOP2013000258A (es)
EA (1) EA201391643A1 (es)
GT (1) GT201300270A (es)
MX (1) MX2013012918A (es)
NI (1) NI201300116A (es)
SG (1) SG194605A1 (es)
TW (1) TW201306881A (es)
WO (1) WO2012154563A1 (es)
ZA (1) ZA201308316B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY140561A (en) 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
AR096223A1 (es) * 2013-05-10 2015-12-16 Glaxosmithkline Llc Pastilla de nicotina para administración oral
BE1021194B1 (nl) * 2014-07-07 2015-07-14 Nordic Specialty Pharma Bvba Paracetamol tabletten
HUE055974T2 (hu) 2015-03-03 2022-01-28 Saniona As Tesofensine és metoprolol kombinációs készítmény
BE1023116B1 (nl) * 2015-07-24 2016-11-23 Nordic Specialty Pharma Bvba Paracetamol omvattend preparaat met vertraagde en aanhoudende afgifte

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4820522A (en) * 1987-07-27 1989-04-11 Mcneilab, Inc. Oral sustained release acetaminophen formulation and process
GB8724763D0 (en) * 1987-10-22 1987-11-25 Aps Research Ltd Sustained-release formulations
US5009895A (en) * 1990-02-02 1991-04-23 Merck & Co., Inc. Sustained release with high and low viscosity HPMC
KR100354702B1 (ko) * 1993-11-23 2002-12-28 유로-셀티크 소시에떼 아노뉨 약학조성물의제조방법및서방형조성물
US20030064108A1 (en) * 1996-04-23 2003-04-03 Stefan Lukas Taste masked pharmaceutical compositions
AUPN940796A0 (en) * 1996-04-23 1996-05-16 F.H. Faulding & Co. Limited Taste masked pharmaceutical compositions
AU9062998A (en) * 1997-09-11 1999-03-29 Nycomed Danmark A/S Modified release multiple-units compositions of non-steroid anti-inflammatory drug substances (nsaids)
IL141762A0 (en) * 1998-10-01 2002-03-10 Novartis Ag New oral formulations
GB0009522D0 (en) * 2000-04-19 2000-06-07 Smithkline Beecham Plc Composition
GB0114069D0 (en) * 2001-06-08 2001-08-01 Smithkline Beecham Plc Composition
PL374922A1 (en) * 2002-07-05 2005-11-14 Temrel Limited Controlled release composition
NZ546182A (en) * 2003-09-26 2009-08-28 Alza Corp Controlled release formulations of opioid and nonopioid analgesics such as hydrocodone and acetaminophen
US20080031901A1 (en) * 2004-09-24 2008-02-07 Abbott Laboratories Sustained release monoeximic formulations of opioid and nonopioid analgesics
BRPI0512756A (pt) * 2004-07-07 2008-04-08 Aft Pharmaceuticals Ltd composição farmacêutica de combinação para o tratamento de dor, método de controle de dor, uso de uma composição e embalagem farmacêutica incluindo comprimidos ou cápsulas
WO2009100118A1 (en) * 2008-02-01 2009-08-13 Abbott Laboratories Extended release hydrocodone acetaminophen and related methods and uses thereof
WO2009114648A1 (en) * 2008-03-11 2009-09-17 Depomed Inc. Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic
AU2009320181B2 (en) * 2008-10-27 2015-08-27 Alza Corporation Extended release oral acetaminophen/tramadol dosage form
US8021420B2 (en) * 2009-03-12 2011-09-20 Medtronic Vascular, Inc. Prosthetic valve delivery system
US20110052685A1 (en) * 2009-08-31 2011-03-03 Depomed, Inc. Gastric retentive pharmaceutical compositions for immediate and extended release of acetaminophen

Also Published As

Publication number Publication date
GT201300270A (es) 2014-12-16
CN103648486A (zh) 2014-03-19
EP2704697A4 (en) 2015-01-07
EA201391643A1 (ru) 2014-07-30
MX2013012918A (es) 2013-11-21
BR112013028668A2 (pt) 2017-01-24
CA2835330A1 (en) 2012-11-15
SG194605A1 (en) 2013-12-30
WO2012154563A1 (en) 2012-11-15
NZ617198A (en) 2016-01-29
ZA201308316B (en) 2014-07-30
AP3878A (en) 2016-10-31
NI201300116A (es) 2014-11-13
EP2704697A1 (en) 2014-03-12
CO6801767A2 (es) 2013-11-29
CL2013003176A1 (es) 2014-07-04
US20140065213A1 (en) 2014-03-06
AU2012253834A1 (en) 2013-12-05
AP2013007224A0 (en) 2013-11-30
AU2012253834B2 (en) 2016-06-16
CR20130572A (es) 2014-03-20
TW201306881A (zh) 2013-02-16
EP2704697B1 (en) 2018-09-12

Similar Documents

Publication Publication Date Title
CY1125061T1 (el) Φαρμακευτικη συνθεση η οποια περιλαμβανει δροσπιρενονη για χρηση ως ενα αντισυλληπτικο
CY1123958T1 (el) Μεθοδος παρασκευης παραγωγων και ενδιαμεσων καρβαμοϋλπυριδονης
CY1124024T1 (el) Νεες ctla4-ig ανοσοπροσκολλητινες
CY1121862T1 (el) Αντισωματα anti-phf-tau και χρησεις αυτων
GT201200284A (es) Composición farmacéutica
JOP20180103B1 (ar) التركيب الصيدلاني للكاربيتوسين
CY1119684T1 (el) Αντι-ιικες ενωσεις
GT201000023A (es) Nuevos derivados de 6-trialzolopiridacina-sulfanil benzotiazol y bencimidazol, su procedimiento de preparacion, su aplicacion como medicamentos, composiciones farmaceuticas y nueva utilizacion principalmente como inhibidores de met.
EA201390804A1 (ru) Лекарственная форма лакозамида для приема один раз в сутки
UY33735A (es) Compuestos antivirales
UY34772A (es) ?una formulación de fármaco de liberación retardada?.
BR112012019529A2 (pt) inibidores de d-nitrosoglutationa redutase
MX336741B (es) Composiciones farmaceuticas de moduladores de c-met.
ECSP12011585A (es) Compuestos y composiciones para eltratamiento de enfermedades parasitarias
MX347734B (es) Anticuerpos anti-s100a4 y usos aplicaciones terapéuticas.
MX2013006644A (es) Formulacion farmaceutica novedosa que comprende nsaid y ciclodextrina.
MX347855B (es) Derivados de anilina, su preparación y su aplicación terapéutica.
EA201291211A1 (ru) Фармацевтические композиции, содержащие гидроморфон и налоксон
HN2010001537A (es) Nuevos derivados dihidroindolonas, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen
CY1121696T1 (el) Φαρμακευτικη συνθεση παρατεταμενης απελευθερωσης της τριμεταζιδινης
MX2009007764A (es) Formulacion de nevirapina de liberacion prolongada.
MX347373B (es) Soluciones anti-inflamatorias estables para inyección.
ES2415029R1 (es) Composición farmacéutica y método para inhibir la producción o amplificar la eliminación de la proteína P24.
NI201300116A (es) Formulaciones de liberación sostenida de paracetamol
UA103290C2 (ru) Фармацевтическая композиция ибупрофена для инъекции